SMN-C3

• Description:

  SMN-C3 (MV8T2MCK57) is an orally active modulator of SMN2 splicing, and has the potential to treat spinal muscular atrophy (SMA) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  416.52

• Molecular Formula:

  C24H28N6O

• Notes:

  Research use only, not for human use.

• Receptor:

  DNA/RNA Synthesis

• CAS Number:

  1449597-34-5